CLC bio and Ingenuity Systems integrate pathway and genomics analysis systems

21 Dec 2010

Your browser does not support inline frames or is currently configured not to display inline frames. US life sciences software developer Ingenuity Systems and Danish bioinformatics company CLC bio are collaborating to provide interoperability between their software solutions.

The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity’s pathway analysis software (IPA), to perform both array and next-generation sequencing data and knowledge analyses.

"As our customers begin to utilize additional research platforms such as next-generation sequencing studies, we see a growing need for solutions that can address the data bottleneck and provide relevant biological context to the data being analyzed,” stated Doug Bassett, Ph.D, Ingenuity’s Chief Scientific Officer and Chief Technology Officer.

“IPA provides high quality, structured biomedical content and analytics, both of which are critical to realize the full potential of high-throughput sequencing data and get to insight quickly. We are enthusiastic to be part of an integrated solution with CLC bio that will enable researchers to get maximum value from both array and NGS data."

Director of Consulting Solutions at CLC bio, Jannick D. Bendtsen, PhD, adds,"The costs of sequencing full genomes are now at a price level where we see a lot of industries and research areas moving into high-throughput sequencing in order to benefit from the added scientific value these new technologies can provide.

"The interoperability of Ingenuity’s IPA with CLC Genomics Server and CLC Genomics Workbench is a solution that will provide an efficient workflow experience for scientists working with large next-generation sequencing datasets, directly from high-performance analyses to biomarker discovery and research diagnostic development."

The first milestone of the partnership is focused upon streamlined workflows between CLC bio's award-winning CLC Genomics Server, CLC Genomics Workbench, and Ingenuity’s IPA.

	CLC bio and Ingenuity Systems integrate pathway and genomics analysis systems 21 Dec 2010 Your browser does not support inline frames or is currently configured not to display inline frames. US life sciences software developer Ingenuity Systems and Danish bioinformatics company CLC bio are collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity’s pathway analysis software (IPA), to perform both array and next-generation sequencing data and knowledge analyses. "As our customers begin to utilize additional research platforms such as next-generation sequencing studies, we see a growing need for solutions that can address the data bottleneck and provide relevant biological context to the data being analyzed,” stated Doug Bassett, Ph.D, Ingenuity’s Chief Scientific Officer and Chief Technology Officer. “IPA provides high quality, structured biomedical content and analytics, both of which are critical to realize the full potential of high-throughput sequencing data and get to insight quickly. We are enthusiastic to be part of an integrated solution with CLC bio that will enable researchers to get maximum value from both array and NGS data." Director of Consulting Solutions at CLC bio, Jannick D. Bendtsen, PhD, adds,"The costs of sequencing full genomes are now at a price level where we see a lot of industries and research areas moving into high-throughput sequencing in order to benefit from the added scientific value these new technologies can provide. "The interoperability of Ingenuity’s IPA with CLC Genomics Server and CLC Genomics Workbench is a solution that will provide an efficient workflow experience for scientists working with large next-generation sequencing datasets, directly from high-performance analyses to biomarker discovery and research diagnostic development." The first milestone of the partnership is focused upon streamlined workflows between CLC bio's award-winning CLC Genomics Server, CLC Genomics Workbench, and Ingenuity’s IPA. To top